14:00
~14:10
|
Àλ縻
̈ȍ
|
±èµ¿Çö (ÇѸ²´ëÇб³ Àǰú´ëÇÐ ±³¼ö, ¿¬±¸Ã¥ÀÓÀÚ)
Áö¼±ÇÏ (Çѱ¹¿ªÇÐȸ ȸÀå)
|
Session 1
ÁÂÀå: Á¤Àº¿Á (°Ç±¹´ëÇб³ ¼öÇаú ±³¼ö, ´ëÇѼöÇÐȸ Äڷγª19 ¼ö¸®¸ðµ¨¸µ TF À§¿øÀå)
|
14:10
~14:30
|
Modeling COVID-19 vaccine elicited antibody dynamics
|
Hyeongki Park (Nagoya University ¹Ú»çÈÄ¿¬±¸¿ø)
|
14:30
~14:50
|
Stratifying COVID-19 vaccine elicited antibody dynamics
|
Shingo Iwami (Nagoya University ±³¼ö)
|
14:50
~15:10
|
Model parameter estimation of COVID-19 using real world data
|
Á¤ÀçÈÆ (°¡Ãµ´ëÇб³ Àǰú´ëÇÐ ±³¼ö)
|
15:10
~15:40
|
Panel Discussion 1
|
Á¶¿µÁö (University of Connecticut ±³¼ö)
Á¤¼º¸ñ (University of North Carolina at Chapel Hill ¹Ú»çÈÄ¿¬±¸¿ø)
À̼±¹Ì (°æÈñ´ëÇб³ ÀÀ¿ë¼öÇаú ±³¼ö)
|
15:40
~16:00
|
Break
|
Session 2
ÁÂÀå: Á¤ÀÏÈ¿ (ºÎ»ê´ëÇб³ ¼öÇаú ±³¼ö, Çѱ¹¼ö¸®»ý¹°ÇÐȸ ȸÀå)
|
16:00
~16:20
|
Age-specific infection patterns of COVID-19 using serological data
|
ÀÌÈ¿Á¤ (°æºÏ´ëÇб³ Åë°èÇаú ±³¼ö)
|
16:20
~16:40
|
Mathematical modeling of COVID-19 based on seroprevalence data
|
°í¿µ¼® (°Ç±¹´ëÇб³ ¼öÇаú ¿¬±¸¿ø)
|
16:40
~17:00
|
µ¥ÀÌÅÍ ±â¹Ý °¨¿°º´ À¯Çà¿¹Ãø¿¡¼ Áúº´Ã»ÀÇ ¿ªÇÒ°ú ¹ßÀü ¹æÇâ
|
À¯¸í¼ö (Áúº´°ü¸®Ã» À§±â´ëÀÀ¿¬±¸´ã´ç°ü ¿¬±¸»ç)
|
17:00
~17:30
|
Panel Discussion 2
|
±è¼º¼ø (Áúº´°ü¸®Ã» À§±â´ëÀÀ¿¬±¸´ã´ç°ü °úÀå)
ÀÌÀç°© (ÇѸ²´ëÇб³ Àǰú´ëÇÐ ±³¼ö)
±ÇÈñ´ë (ÀÎÇÏ´ëÇб³ ¼öÇаú ±³¼ö)
|